You just read:

ImStem Biotechnology Announces FDA has Lifted the Clinical Hold on the Investigational New Drug Application for IMS001 for the Treatment of Multiple Sclerosis

News provided by

ImStem Biotechnology, Inc.

Mar 20, 2020, 17:49 ET